JP2024538148A5 - - Google Patents
Info
- Publication number
- JP2024538148A5 JP2024538148A5 JP2024522646A JP2024522646A JP2024538148A5 JP 2024538148 A5 JP2024538148 A5 JP 2024538148A5 JP 2024522646 A JP2024522646 A JP 2024522646A JP 2024522646 A JP2024522646 A JP 2024522646A JP 2024538148 A5 JP2024538148 A5 JP 2024538148A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256705P | 2021-10-18 | 2021-10-18 | |
| US63/256,705 | 2021-10-18 | ||
| PCT/US2022/078192 WO2023069888A1 (en) | 2021-10-18 | 2022-10-17 | ANTI-EGFR ANTIBODIES, ANTI-cMET ANTIBODIES, ANTI-VEGF ANTIBODIES, MULTISPECIFIC ANTIBODIES, AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024538148A JP2024538148A (ja) | 2024-10-18 |
| JP2024538148A5 true JP2024538148A5 (https=) | 2025-10-22 |
| JPWO2023069888A5 JPWO2023069888A5 (https=) | 2025-10-22 |
Family
ID=84267971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522646A Pending JP2024538148A (ja) | 2021-10-18 | 2022-10-17 | 抗ＥＧＦＲ抗体、抗ｃＭＥＴ抗体、抗ＶＥＧＦ抗体、多重特異性抗体及びそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250230248A1 (https=) |
| EP (1) | EP4419556A1 (https=) |
| JP (1) | JP2024538148A (https=) |
| KR (1) | KR20240099227A (https=) |
| CN (1) | CN118355030A (https=) |
| AU (1) | AU2022369278A1 (https=) |
| CA (1) | CA3232216A1 (https=) |
| WO (1) | WO2023069888A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4454705A1 (en) * | 2023-04-28 | 2024-10-30 | Jost B. Jonas | Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of retinal pigment epithelium (rpe) cells |
| WO2025056713A1 (en) * | 2023-09-12 | 2025-03-20 | Jonas Jost B | Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and/or metaplasia of retinal pigment epithelium (rpe) cells |
| WO2025108427A1 (zh) * | 2023-11-23 | 2025-05-30 | 橙帆生物医药公司 | 结合分子及抗体药物偶联物和用途 |
| CN118085101A (zh) * | 2024-03-01 | 2024-05-28 | 烟台蓝纳成生物技术有限公司 | 一种二价双特异性抗体、抗体偶联核素药物及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| EP1789446A2 (en) | 2004-09-02 | 2007-05-30 | Genentech, Inc. | Heteromultimeric molecules |
| EP3050963B1 (en) | 2005-03-31 | 2019-09-18 | Chugai Seiyaku Kabushiki Kaisha | Process for production of polypeptide by regulation of assembly |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| EP1934259A2 (en) * | 2005-10-11 | 2008-06-25 | Ablynx N.V. | Nanobodies and polypeptides against egfr and igf-ir |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| BRPI1014449A2 (pt) | 2009-04-07 | 2017-06-27 | Roche Glycart Ag | anticorpos biespecíficos anti-erbb-2/ anti-c-met. |
| JP2012525149A (ja) | 2009-04-27 | 2012-10-22 | オンコメッド ファーマシューティカルズ インコーポレイテッド | ヘテロ多量体分子を作製するための方法 |
| CN103889451B (zh) * | 2011-09-30 | 2016-06-29 | 埃博灵克斯股份有限公司 | 与C-Met相关的生物物质 |
| CN113201073A (zh) * | 2012-11-21 | 2021-08-03 | 詹森生物科技公司 | 双特异性EGFR/c-Met抗体 |
| US20170275367A1 (en) | 2012-11-21 | 2017-09-28 | Janssen Biotech, Inc. | Bispecific EGFR/C-Met Antibodies |
| KR102089591B1 (ko) | 2013-07-29 | 2020-03-18 | 삼성전자주식회사 | 항 EGFR scFv 단편 및 이를 포함하는 항 c-Met/항 EGFR 이중 특이 항체 |
| HUE046936T2 (hu) | 2014-11-27 | 2020-04-28 | Panasonic Ip Man Co Ltd | Üvegtábla-egység |
| CN108350078A (zh) | 2015-11-03 | 2018-07-31 | 默克专利股份公司 | 用于提高肿瘤选择性和抑制的双特异性抗体及其用途 |
-
2022
- 2022-10-17 JP JP2024522646A patent/JP2024538148A/ja active Pending
- 2022-10-17 KR KR1020247014165A patent/KR20240099227A/ko active Pending
- 2022-10-17 CA CA3232216A patent/CA3232216A1/en active Pending
- 2022-10-17 EP EP22800983.3A patent/EP4419556A1/en active Pending
- 2022-10-17 WO PCT/US2022/078192 patent/WO2023069888A1/en not_active Ceased
- 2022-10-17 AU AU2022369278A patent/AU2022369278A1/en active Pending
- 2022-10-17 US US18/701,582 patent/US20250230248A1/en active Pending
- 2022-10-17 CN CN202280070414.4A patent/CN118355030A/zh active Pending